Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Covington
Federal Trade Commission
Colorcon
Harvard Business School
Merck
Julphar
Cerilliant
McKesson
Citi

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,294,978

« Back to Dashboard

Summary for Patent: 6,294,978
Title: High-current fuse for vehicles
Abstract:A high-current fuse for vehicles is provided. This high-current fuse includes a conductive plate having a fuse and terminal connecting portions on both ends, and a resin case into which the conductive plate is insert-molded. A heat radiating portion for releasing heat generated from the fuse and the conductive plate when energized is provided on the outer surface of the resin case. The heat radiating portion is made up of a plurality of thin plates arranged on the resin case at regular intervals. The thin plates are situated in parallel with the energizing direction so as to strengthen the resin case. To keep the fuse away from both ends of the conductive plate, a pair of assisting plates facing to each other are formed in the middle of the conductive plate, and the fuse is disposed between the assisting plates. The fuse between the assisting plates is in the direction perpendicular to the energizing direction of the conductive plate.
Inventor(s): Endo; Takayoshi (Shizuoka, JP), Matsumura; Norio (Shizuoka, JP), Inaba; Shigemitsu (Shizuoka, JP), Hikage; Atsushi (Shizuoka, JP), Onoda; Shinya (Shizuoka, JP)
Assignee: Yazaki Corporation (Tokyo, JP)
Application Number:09/267,698
Patent Claim Types:
see list of patent claims

Drugs Protected by US Patent 6,294,978

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,294,978

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan10-065486Mar 16, 1998
Japan10-265936Sep 21, 1998
Japan10-369339Dec 25, 1998

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Mallinckrodt
Harvard Business School
US Department of Justice
Novartis
Citi
Deloitte
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot